New therapy wiped out Gen Zer's rectal cancer in just 4 months
New York Post • • health
Key Points:
- Journalist Mrinali Dhembla, 27, was diagnosed with aggressive Stage 3 rectal cancer that had spread to her spine shortly after getting engaged, highlighting a rise in colorectal cancer among adults under 50.
- Genetic testing revealed she has Lynch syndrome, an inherited condition that impairs DNA repair, making tumors more vulnerable to immunotherapy but necessitating earlier cancer screening.
- Dhembla became one of the first patients treated with a dual-immunotherapy regimen of nivolumab and ipilimumab, which led to a remarkable response and complete remission within four months.
- This treatment helped her avoid complex surgery and permanent colostomy, with manageable side effects like hypothyroidism, now controlled with medication.
